secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avid Bioservices, Inc. (—)
CIK:        0000704562
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001140361-25-003108
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GHO Capital and Ampersand complete $1.12B acquisition of Avid Bioservices
-------------------------------------------------------------------------

- All-cash consideration of $12.50 per share; deal closed Feb 5, 2025.
- Avid common stock delisted from Nasdaq; trading halted at closing.
- Convertible note holders: repurchase right and increased conversion rate (113.7656 shares per $1,000) until Mar 10, 2025.
- Board changes: Nicholas Green remains; Daniel Hart appointed; prior directors resign.
- GHO and Ampersand plan to expand Avid's CDMO capabilities, talent, and geographic reach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704562/000114036125003108/0001140361-25-003108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704562/000114036125003108/ef20042864_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-003108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer